The recent case involving Rebecca Fadanelli, owner of Skin Beaute Med Spa, who was arrested on November 1, 2024, on charges of illegal medical practices, is a stark reminder of the importance of integrity and compliance within the med spa industry. While this...
In a surprising turn of events, the U.S. Food and Drug Administration (FDA) has agreed to reconsider its decision to remove tirzepatide, the active ingredient in Eli Lilly’s diabetes therapy Mounjaro and weight loss therapy Zepbound, from its drug shortage list. This...
The pharmaceutical landscape is once again at the center of a legal battle. This time, the battle involves the popular drug tirzepatide, manufactured by Eli Lilly under the brand name Mounjaro. Compounders, the small but crucial segment of the pharmaceutical world,...
Recent developments regarding weight loss drugs and the FDA’s policies on compounding pharmacies have sparked significant changes in the healthcare and wellness sectors. With the FDA announcing that Eli Lilly’s popular weight loss drug, Tirzepatide, is no longer...
August 21, 2024 In a landmark decision, Judge Ada Brown of the United States District Court for the Northern District of Texas has overruled the Federal Trade Commission’s (FTC) sweeping ban on non-compete agreements. This ruling marks a significant development...
The beauty industry never stands still, constantly unveiling new and innovative treatments. Two recent additions that have generated buzz are the salmon sperm facial and exosome therapy. While these treatments promise remarkable results, it’s essential to...
